JR Pharma Engineering ApS: Financial statements 2026
CVR: 42398993
Source: annual report 2026, Danish Business Authority
01/07/2025 – 30/06/2026
JR Pharma Engineering ApS (CVR 42398993) has filed annual accounts for 2026. In 2026, the company reported revenue of DKK 2,000,220 and a net result of DKK 432,091 compared with DKK 591,630 the year before. That is an increase of 3.9% compared with the year before. The profit margin was 21.6%. Equity in the 2026 report amounted to DKK 474,033. The solvency ratio was 49.9%.
- Revenue
- DKK 2,000,220
- Gross Profit
- DKK 1,959,070
- Profit/Loss
- DKK 432,091
- Equity
- DKK 474,033
- Total Assets
- DKK 950,678
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | 2 mio. | 2 mio. | 432 t. | 474 t. | - |
| 2025 | 1.9 mio. | 1.9 mio. | 592 t. | 634 t. | - |
| 2024 | 2 mio. | 1.9 mio. | 651 t. | 693 t. | - |
| 2023 | 1.9 mio. | 1.8 mio. | 645 t. | 687 t. | - |
Official annual report
Find more companies like JR Pharma Engineering ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout JR Pharma Engineering ApS
JR Pharma Engineering ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2021. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for byggeri og anlægsarbejder. The management consists of Jimmy Rønne Jensen. The company is owned by JR Pharma Engineering Holding ApS. In 2026, the company reported revenue of DKK 2,000,220 and a net result of DKK 432,091 compared with DKK 591,630 the year before. Equity in the 2026 report amounted to DKK 474,033.